These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11424186)

  • 1. Estimation of the average burst size of Phix174 am3, cs70 for use in mutation assays with transgenic mice.
    Delongchamp RR; Valentine CR; Malling HV
    Environ Mol Mutagen; 2001; 37(4):356-60. PubMed ID: 11424186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three origins of phiX174 am3 revertants in transgenic cell culture.
    Malling HV; Delongchamp RR; Valentine CR
    Environ Mol Mutagen; 2003; 42(4):258-73. PubMed ID: 14673871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct separation of in vivo and in vitro am3 revertants in transgenic mice carrying the phiX174 am3, cs70 vector.
    Malling HV; Delongchamp RR
    Environ Mol Mutagen; 2001; 37(4):345-55. PubMed ID: 11424185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo mutation in gene A of splenic lymphocytes from phiX174 transgenic mice.
    Valentine CR; Raney JL; Shaddock JG; Dobrovolsky VN; Delongchamp RR
    Environ Mol Mutagen; 2004; 44(2):128-50. PubMed ID: 15278917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a microplate assay for the detection of single plaque-forming units of bacteriophage PhiX174 in crude lysates.
    Slattery SD; Valentine CR
    Environ Mol Mutagen; 2003; 41(2):121-5. PubMed ID: 12605381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo mutation analysis using the ΦX174 transgenic mouse and comparisons with other transgenes and endogenous genes.
    Valentine CR; Delongchamp RR; Pearce MG; Rainey HF; Dobrovolsky VN; Malling HV; Heflich RH
    Mutat Res; 2010 Dec; 705(3):205-16. PubMed ID: 20637298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo but not the in vitro am3 revertant frequencies increase linearly with increased ethylnitrosourea doses in spleen of mice transgenic for phiX174 am3, cs70 using the single burst assay.
    Weaver RP; Malling HV
    Mutat Res; 2003 Jan; 534(1-2):1-13. PubMed ID: 12504750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
    Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
    Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation frequencies but not mutant frequencies in Big Blue mice fit a Poisson distribution.
    Nishino H; Schaid DJ; Buettner VL; Haavik J; Sommer SS
    Environ Mol Mutagen; 1996; 28(4):414-7. PubMed ID: 8991071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the phiX174 am3 allele in relation to the endogenous Hprt gene for detecting mutation in transgenic mice.
    Chen JB; Dass SB; Burkhart JG; Heflich RH
    Environ Mol Mutagen; 1998; 32(3):229-35. PubMed ID: 9814437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of a single AT basepair in mice transgenic for PhiX174 am3, cs70. II. Brain.
    Malling HV; Newbold RR; Lewis S; Barnett L; Weaver RP
    Mutat Res; 1999 Jul; 444(1):85-95. PubMed ID: 10477342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional origins of fitness effect-sizes of compensatory mutations in the DNA bacteriophage phiX174.
    Poon AF; Chao L
    Evolution; 2006 Oct; 60(10):2032-43. PubMed ID: 17133860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous mutant frequency and mutation spectrum for gene A of phiX174 grown in E. coli.
    Raney JL; Delongchamp RR; Valentine CR
    Environ Mol Mutagen; 2004; 44(2):119-27. PubMed ID: 15278916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis of a single AT basepair in mice transgenic for PhiX174 am3 cs70 I. Spleen and testis.
    Malling HV; Weaver RP
    Mutat Res; 1998 Feb; 412(3):271-81. PubMed ID: 9600695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous mutation in Big Blue mice from fetus to old age: tissue-specific time courses of mutation frequency but similar mutation types.
    Hill KA; Buettner VL; Halangoda A; Kunishige M; Moore SR; Longmate J; Scaringe WA; Sommer SS
    Environ Mol Mutagen; 2004; 43(2):110-20. PubMed ID: 14991751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for large-size mutations.
    Deutsch S
    IEEE Trans Biomed Eng; 2001 Jan; 48(1):124-7. PubMed ID: 11235586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An estimator of the mutant frequency in assays using transgenic animals.
    Delongchamp RR; Malling HV; Chen JB; Heflich RH
    Mutat Res; 1999 Mar; 440(1):101-8. PubMed ID: 10095133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable epistatic effects between mutations at host recognition sites in phiX174 bacteriophage.
    Pepin KM; Wichman HA
    Evolution; 2007 Jul; 61(7):1710-24. PubMed ID: 17598750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational spectra in transgenic animal research: data analysis and study design based upon the mutant or mutation frequency.
    Carr GJ; Gorelick NJ
    Environ Mol Mutagen; 1996; 28(4):405-13. PubMed ID: 8991070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing bacteriophage plaque fecundity.
    Abedon ST; Culler RR
    J Theor Biol; 2007 Dec; 249(3):582-92. PubMed ID: 17919662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.